StockData

Research Alliance Corp III (RACC) stock

RACCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026
$10.01−0.06 (-0.60%)

Close on Nov 19, 2026Market cap $91.08MP/E –Yield –

Research Alliance Corp III net income

Net income is the profit left for shareholders after every expense, interest and tax.

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$1.95M–
Q2 FY2026Jun 30, 2026$54.05K–

More Research Alliance Corp III figures

See a number that looks wrong?